Geode Capital Management, LLC Genmab A/S Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Genmab A/S stock. As of the latest transaction made, Geode Capital Management, LLC holds 43,231 shares of GMAB stock, worth $890,126. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,231

Previous 43,311 0.18%

Holding current value

$890,126

Previous $1.09 Million 3.22%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$23.84 - $28.48 $1,907 - $2,278	-80 Reduced 0.18%	43,231 $1.05 Million
Q2 2024 Aug 09, 2024	BUY	$25.13 - $30.27 $8,845 - $10,655	352 Added 0.82%	43,311 $1.09 Million
Q1 2024 May 13, 2024	BUY	$26.43 - $32.77 $41,838 - $51,874	1,583 Added 3.83%	42,959 $1.28 Million
Q4 2023 Feb 13, 2024	SELL	$27.94 - $35.44 $10,142 - $12,864	-363 Reduced 0.87%	41,376 $1.32 Million
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $846 - $1,013	24 Added 0.06%	41,739 $1.47 Million
Q2 2023 Aug 11, 2023	BUY	$37.4 - $42.94 $15,259 - $17,519	408 Added 0.99%	41,715 $1.59 Million
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $18,660 - $23,122	-535 Reduced 1.28%	41,307 $1.56 Million
Q4 2022 Feb 13, 2023	SELL	$33.8 - $47.06 $10,613 - $14,776	-314 Reduced 0.74%	41,842 $1.77 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $20,424 - $242,099	648 Added 1.56%	42,156 $1.35 Million
Q2 2022 Aug 12, 2022	SELL	$26.83 - $38.57 $111,746 - $160,644	-4,165 Reduced 9.12%	41,508 $1.35 Million
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $689,163 - $883,554	-22,267 Reduced 32.77%	45,673 $1.65 Million
Q4 2021 Feb 11, 2022	BUY	$35.87 - $47.12 $382,087 - $501,922	10,652 Added 18.59%	67,940 $2.69 Million
Q3 2021 Nov 12, 2021	BUY	$41.55 - $48.72 $360,570 - $422,792	8,678 Added 17.85%	57,288 $2.5 Million
Q2 2021 Aug 13, 2021	SELL	$32.88 - $44.57 $426,420 - $578,028	-12,969 Reduced 21.06%	48,610 $1.99 Million
Q1 2021 May 12, 2021	BUY	$30.92 - $44.4 $257,007 - $369,052	8,312 Added 15.6%	61,579 $2.02 Million
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $120,031 - $145,350	3,566 Added 7.17%	53,267 $2.17 Million
Q3 2020 Nov 13, 2020	BUY	$33.07 - $38.68 $270,413 - $316,286	8,177 Added 19.69%	49,701 $1.82 Million
Q2 2020 Aug 13, 2020	BUY	$20.05 - $33.89 $247,838 - $418,914	12,361 Added 42.39%	41,524 $1.41 Million
Q1 2020 May 14, 2020	BUY	$17.15 - $25.22 $196,453 - $288,895	11,455 Added 64.69%	29,163 $617,000
Q4 2019 Feb 13, 2020	SELL	$18.88 - $24.14 $58,509 - $74,809	-3,099 Reduced 14.89%	17,708 $395,000
Q3 2019 Nov 12, 2019	BUY	$18.0 - $21.38 $374,526 - $444,853	20,807 New	20,807 $421,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Genmab A/S Transaction History